Task: Answer the MCQ question.
Question: Which drug exhibits a -31.519% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
(a) CCOC(=O)CSc1cc(C(F)(F)F)nc(-c2ccccn2)n1
(b) CC1CCN(S(=O)(=O)c2ccc3ncn(CC(=O)N(C)C4CCCCC4)c(=O)c3c2)CC1
(c) COC(=O)COc1ccc(S(=O)(=O)N2CCCCCC2)cc1
(d) Nc1ccc(-c2cc(N)n(-c3ccccc3)n2)cc1
(e) CC1=CC(C)(C)n2c(O)c(C3=NC(=S)NC3=O)c3cc(OC(=O)c4cccc5ccccc45)cc1c32
Answer: a. CCOC(=O)CSc1cc(C(F)(F)F)nc(-c2ccccn2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)CSc1cc(C(F)(F)F)nc(-c2ccccn2)n1
CCOC(=O)CSc1cc(C(F)(F)F)nc(-c2ccccn2)n1
ethyl 2-[2-pyridin-2-yl-6-(trifluoromethyl)pyrimidin-4-yl]sulfanylacetate